Cofoe Medical Technology Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100004Y98
CNY
43.46
-0.97 (-2.18%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
1,012.37
989.71
902.03
757.97
737.79
734.28
690.04
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,012.37
989.71
902.03
757.97
737.79
734.28
690.04
Raw Material Cost
454.01
504.53
444.21
386.97
382.11
374.19
355.88
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.90
5.05
3.70
4.44
2.87
4.79
4.61
Selling and Distribution Expenses
396.80
357.75
343.05
262.38
243.06
258.77
250.83
Other Expenses
1.92
2.01
1.63
1.57
1.49
2.06
1.73
Total Expenditure (Excl Depreciation)
872.89
887.43
807.26
669.50
642.96
658.33
628.65
Operating Profit (PBDIT) excl Other Income
139.5
102.30000000000001
94.80000000000001
88.5
94.80000000000001
76
61.4
Other Income
16.95
3.65
16.56
17.55
41.65
12.10
27.68
Operating Profit (PBDIT)
129.59
148.57
161.81
137.23
151.34
126.31
125.25
Interest
2.90
5.05
3.70
4.44
2.87
4.79
4.61
Exceptional Items
5.13
35.96
2.91
3.69
7.29
6.91
5.04
Gross Profit (PBDT)
558.36
485.17
457.82
371.01
355.68
360.09
334.16
Depreciation
0.00
57.22
57.22
46.61
46.61
47.43
47.43
Profit Before Tax
131.82
122.25
103.79
89.87
109.15
81.00
78.26
Tax
21.62
10.86
11.65
15.16
17.85
16.64
11.59
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
107.04
111.39
92.83
75.96
91.43
59.83
66.94
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
107.04
111.39
92.83
75.96
91.43
59.83
66.94
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.37
-0.58
0.03
-0.89
0.15
0.57
0.29
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
107.41
110.81
92.86
75.07
91.57
60.41
67.23
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
0.0
0.0
0.0
0.0
0.0
Reserves
4,731.84
4,866.86
4,713.66
4,737.68
4,893.68
4,796.60
4,743.09
Earnings per share (EPS)
0.51
0.54
0.46
0.36
0.45
0.28
0.33
Diluted Earnings per share
0.51
0.54
0.46
0.36
0.45
0.28
0.33
Operating Profit Margin (Excl OI)
11.13%
8.86%
9.76%
9.64%
8.55%
9.1%
7.27%
Gross Profit Margin
13.02%
18.13%
17.85%
18.01%
21.11%
17.49%
18.21%
PAT Margin
10.57%
11.25%
10.29%
10.02%
12.39%
8.15%
9.7%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 37.22% vs -8.60% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 17.25% vs -9.31% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 2.64% vs -23.55% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is 0.00% vs 7.41% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of Cofoe Medical Technology Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,012.37
0
1,012.37
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,012.37
0
1,012.37
Raw Material Cost
454.01
0
454.01
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2.90
0
2.90
Selling and Distribution Expenses
396.80
0
396.80
Other Expenses
1.92
0.00
1.92
Total Expenditure (Excl Depreciation)
872.89
0
872.89
Operating Profit (PBDIT) excl Other Income
139.48
0.00
139.48
Other Income
16.95
0
16.95
Operating Profit (PBDIT)
129.59
0
129.59
Interest
2.90
0
2.90
Exceptional Items
5.13
0
5.13
Gross Profit (PBDT)
558.36
0
558.36
Depreciation
0.00
0
0.00
Profit Before Tax
131.82
0
131.82
Tax
21.62
0
21.62
Provisions and contingencies
0
0
0.00
Profit After Tax
107.04
0
107.04
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
107.04
0
107.04
Share in Profit of Associates
0
0
0.00
Minority Interest
0.37
0
0.37
Other related items
0.00
0.00
0.00
Consolidated Net Profit
107.41
0
107.41
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,731.84
0
4,731.84
Earnings per share (EPS)
0.51
0
0.51
Diluted Earnings per share
0.51
0
0.51
Operating Profit Margin (Excl OI)
11.13%
0%
0.00
11.13%
Gross Profit Margin
13.02%
0%
0.00
13.02%
PAT Margin
10.57%
0%
0.00
10.57%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 101.24 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 2.29% vs 9.72% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 37.22% vs -8.60% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 10.74 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -3.07% vs 19.27% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 17.25% vs -9.31% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.26 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -22.29% vs -0.28% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 2.64% vs -23.55% in Mar 2025

Quarterly - Interest
Interest 0.29 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -43.14% vs 37.84% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 0.00% vs 7.41% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.13%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025